Lexeo Therapeutics, Inc. (LXEO) Net Cash Flow (2022 - 2023)
Lexeo Therapeutics' Net Cash Flow history spans 2 years, with the latest figure at $86.0 million for Q4 2023.
- For Q4 2023, Net Cash Flow rose 611.58% year-over-year to $86.0 million; the TTM value through Dec 2023 reached $44.2 million, changed N/A, while the annual FY2024 figure was -$86.5 million, 295.9% down from the prior year.
- Net Cash Flow for Q4 2023 was $86.0 million at Lexeo Therapeutics, up from -$10.1 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $86.0 million in Q4 2023 and bottomed at -$18.5 million in Q1 2023.